
Current Price | $61.60 | Mkt Cap | $77.3B |
---|---|---|---|
Open | $61.00 | P/E Ratio | 17.13 |
Prev. Close | $61.60 | Div. (Yield) | $2.92 (4.7%) |
Daily Range | $60.81 - $61.71 | Volume | 10 |
52-Wk Range | $57.17 - $74.12 | Avg. Daily Vol. | 6,805,650 |
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
Current Price | $61.60 | Mkt Cap | $77.3B |
---|---|---|---|
Open | $61.00 | P/E Ratio | 17.13 |
Prev. Close | $61.60 | Div. (Yield) | $2.92 (4.7%) |
Daily Range | $60.81 - $61.71 | Volume | 10 |
52-Wk Range | $57.17 - $74.12 | Avg. Daily Vol. | 6,805,650 |
The best Bull and Bear pitches based on recency and number of recommendations.
This company has proved that it can cure diseases. It has over $30B in cash. Good mgmt. Good yield. As of today at has a P/E of 7. If this company was not here tomorrow, people would notice.
I have a real hard time imagining that Gilead will have sold enough Remdesivir to make this stock a market performer much less a market *beater.* I do continue to own shares in my real portfolio though, so I'm happy to be proven wrong. Underperform.
Read the most recent pitches from players about GILD.
Recs
Large moat industry with modest inflationary protection with above market dividends
Recs
good quality and value
Recs
Despite declining HIV drug sales, the company's growing oncology pipeline will help it increase revenue.
Find the members with the highest scoring picks in GILD.
BrianMotleyFool (71.64) Score: +536.73
The Score Leader is the player with the highest score across all their picks in GILD.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
janleszek | < 20 | 3/30/2009 |
![]() |
3M | $18.03 | +241.69% | +423.44% | +181.76 | 0 Comment | |
WilliamCrook2003 | 72.23 |
|
![]() |
5Y | $12.82 | +380.38% | +208.33% | +172.05 | 1 Comment | |
UrineLuck73 | 40.20 | 1/29/2007 |
![]() |
NS | $12.82 | +380.38% | +208.33% | +172.05 | 0 Comment | |
predragj | 39.25 | 1/30/2007 |
![]() |
NS | $12.99 | +374.30% | +207.98% | +166.32 | 0 Comment | |
mxdfool | < 20 | 12/15/2006 |
![]() |
5Y | $13.05 | +372.13% | +206.92% | +165.21 | 0 Comment | |
betsypurcell | < 20 | 1/24/2007 |
![]() |
NS | $13.07 | +371.48% | +206.65% | +164.83 | 0 Comment | |
leoladot | < 20 | 1/5/2009 |
![]() |
3M | $21.26 | +189.80% | +354.13% | +164.33 | 1 Comment | |
rmarinchek | < 20 | 1/25/2007 |
![]() |
3W | $13.16 | +367.94% | +204.79% | +163.15 | 0 Comment | |
Redskins2k9 | < 20 | 1/25/2007 |
![]() |
5Y | $13.16 | +367.94% | +204.79% | +163.15 | 0 Comment | |
opveiby | 79.44 | 1/25/2007 |
![]() |
5Y | $13.16 | +367.94% | +204.79% | +163.15 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.